[1] Malespin M, Nassri A. Endocrine diseases and the liver: an update [J]. Clin Liver Dis, 2019, 23(2): 233-246.
[2] 任艳婷, 王娟娟, 付怀云, 等. 甲状腺功能亢进症患者肝功能损害176例临床分析 [J]. 基层医学论坛, 2012, 16(5): 583-585.
[3] Zhang R, Tian X, Qin L, et al. Factors predicting abnormal liver function tests induced by Graves' disease alone: a retrospective cohort study [J]. Medicine (Baltimore), 2015, 94(19): e839.
[4] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版) [J]. 临床肝胆病杂志, 2019, 35(1): 38-44.
[5] 刘红丽. 甲状腺功能亢进性肝病患者血清检验指标改变的临床意义 [J]. 临床合理用药杂志, 2020, 13(23): 163-165.
[6] 肖金玉, 王晓胥, 康联宗. 甲亢性肝病患者血清学指标检验及临床价值分析 [J]. 贵州医药, 2019, 43(9): 1481-1482.
[7] Tritto C, Correale E, Tesauro P, et al. Hepatic blood flow and cardiac output in hyperthyroidism [J]. Rass Int Clin Ter, 1966, 46(5): 225-228.
[8] Herrera J L. The liver in systemic disease [J]. Clin Liver Dis, 2019, 23(2): xiii-xiv.
[9] 姚珍, 蔡慧琳, 张晓媚. 甲状腺功能亢进患者甲状腺激素水平与代谢指标的关系分析 [J]. 名医, 2022, 08): 90-92.
[10] PiantanidaI E, Ippolito S, Gallo D, et al. The interplay between thyroid and liver: implications for clinical practice [J]. J Endocrinol Invest, 2020, 43(7): 885-899.
[11] Zeng J, Luo F, Lin Z, et al. Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves's disease: a case report and literature review [J]. BMC Endocr Disord, 2021, 21(1): 179.
[12] Ozenírler S, Tuncer C, Boztepe U, et al. Propylthiouracil-induced hepatic damage [J]. Ann Pharmacother, 1996, 30(9): 960-963.
[13] Ross D S, Burch H B, Cooper D S, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis [J]. Thyroid, 2016, 26(10): 1343-1421.
[14] Chiha M, Samarasinghe S, Kabaker A S. Thyroid storm: an updated review [J]. J Intensive Care Med, 2015, 30(3): 131-140.
[15] 赵德善, 李灵敏. 甲状腺功能亢进伴发轻度肝功能损害患者的131碘治疗 [J]. 中华内分泌代谢杂志, 2004, 20(2): 38-39. |
